HAE
HAE
US4050241003
Haemonetics Corporation
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
5.4B EUR
3.41B EUR
2.55B EUR
3.75B EUR
Enterprise Value
6.39B EUR
4.36B EUR
3.53B EUR
4.61B EUR
Valuation Multiples
Trailing P/E
57.34x
35.42x
26.21x
31.96x
Forward P/E
20.4x
--
--
--
Price to Sales
3.99x
2.52x
1.91x
3.8x
Price to Book
6.45x
4.07x
3.2x
4.12x
EV/Revenue
4.72x
3.23x
2.65x
4.67x
EV/EBITDA
17.8x
12.28x
10x
16.88x
Price to FCF (P/FCF)
17.26x
11.71x
9.79x
18.12x
EV/FCF
20.41x
14.98x
13.55x
22.28x
FCF Yield
5.79%
8.54%
10.21%
5.52%
ende